Mariajosé Lechuga

2.4k citations
22 papers · 1.0k indexed · 1 hit paper · h-index 12
Topics
Renal cell carcinoma treatment (11 papers)Cancer Genomics and Diagnostics (6 papers)Pancreatic and Hepatic Oncology Research (4 papers)

In The Last Decade

Mariajosé Lechuga

22 papers receiving 990 citations

Hit Papers

Axitinib in combination with pembrolizumab in patients wi...2018202620202023201850100150200250

Peers

Mariajosé Lechuga
Comparison fields: 5 of 67
  • Pulmonary and Respiratory Medicine 570
  • Oncology 480
  • Molecular Biology 269
  • Cancer Research 252
  • Pharmacology 158
Replace K.A. Mason with:
K.A. Mason United States
Leni van Doorn Netherlands
Reiko Masunaga Japan
Edward H. Lin United States
Tamami Morisaki Japan
A-P Meert Belgium
Elmer Berghorn United States
Muneaki Shibakita Japan
Han Ik Bae South Korea
Yongchun Song China
Mariajosé Lechuga relative to K.A. Mason United States K.A. Mason's profile →
Citations per field
00.5×8.8×
K.A. Mason · 1×
Citations per year

Countries citing papers authored by Mariajosé Lechuga

Since Specialization
Citations

This map shows the geographic impact of Mariajosé Lechuga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariajosé Lechuga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariajosé Lechuga more than expected).

Fields of papers citing papers by Mariajosé Lechuga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariajosé Lechuga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariajosé Lechuga. The network helps show where Mariajosé Lechuga may publish in the future.

Co-authorship network of co-authors of Mariajosé Lechuga

This figure shows the co-authorship network connecting the top 25 collaborators of Mariajosé Lechuga. A scholar is included among the top collaborators of Mariajosé Lechuga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariajosé Lechuga. Mariajosé Lechuga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 35
3 16
4 32
5 176
6
Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trialbreakdown →
274
7 2
8 7
9 1
10 8
11 1
12 1
13 63
14 12
15 35
16 4
17 13
18 91
19 22
20 206

About Mariajosé Lechuga

Mariajosé Lechuga is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 22 papers that have together received 1.0k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (11 papers), Cancer Genomics and Diagnostics (6 papers) and Pancreatic and Hepatic Oncology Research (4 papers). The work is most often cited by research in Oncology (480 citations), Pulmonary and Respiratory Medicine (570 citations) and Cancer Research (252 citations). Mariajosé Lechuga has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Brad Rosbrook, Ulka N. Vaishampayan, Elizabeth R. Plimack, Toni K. Choueiri, Jamal Tarazi, Thomas Olencki, Michael B. Atkins, Mayer Fishman, Kathrine C. Fernandez and Saby George. Their work appears in journals such as Circulation, Journal of Clinical Oncology and The Lancet Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026